Open Label Dose-Finding Study of TRC105 Plus Capecitabine for Metastatic Breast Cancer

This study is currently recruiting participants.
Verified July 2013 by Tracon Pharmaceuticals Inc.
Sponsor:
Collaborators:
Roswell Park Cancer Institute
Information provided by (Responsible Party):
Tracon Pharmaceuticals Inc.
ClinicalTrials.gov Identifier:
NCT01326481
First received: March 25, 2011
Last updated: July 11, 2013
Last verified: July 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2013
  Estimated Primary Completion Date: August 2013 (Final data collection date for primary outcome measure)